Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
cetirizine hydrochloride, Quantity: 1 mg/mL
NOUMED PHARMACEUTICALS PTY LTD
Oral Liquid, solution
Excipient Ingredients: sorbitol solution (70 per cent) (non-crystallising); propylene glycol; glycerol; propyl hydroxybenzoate; methyl hydroxybenzoate; sodium citrate dihydrate; citric acid monohydrate; purified water; Flavour
Oral
200 mL (glass), 100 mL (PET), 100mL (glass), 200mL (PET)
(S2) Pharmacy Medicine
Seasonal allergic rhinitis: Cetirizine is indicated for the relief of symptoms associated with seasonal allergic rhinitis (hay fever) in adults and children aged 1-12 years. Symptoms treated effectively include sneezing, rhinorrhoea, post-nasal discharge, nasal pruritus, ocular pruritus and tearing and redness of the eyes. , Perennial allergic rhinitis: Cetirizine is indicated for the relief of symptoms associated with perennial allergic rhinitis in adults and children aged 1-12 years. Symptoms treated effectively include sneezing, rhinorrhoea, post-nasal discharge, nasal pruritus, ocular pruritus and tearing. , Chronic idiopathic urticaria: Cetirizine is indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children aged 1-12 years. It significantly reduces the occurrence, severity and duration of hives and markedly reduces pruritus. As with other antihistamines, patients should be advised to seek medical advice about the possibility that their urticaria is associated with ingestion of certain foods.
Visual Identification: A clear colourless solution; Container Type: Bottle; Container Material: Polyethylene Terephthalate; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure
Registered
2019-02-08